All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
GMPs Specifically for Manufacturing Homeopathic Products
By Mark Land, MS, RAC-US, AAHP President The first time I read the drug GMP regulations at 21 CFR 210 & 211, I thought to...
An Overview Application of a Quality-by-Design Model for Hahnemannian Dilutions
By William Shevin, M.D., President, HPCUS, and Eric L. Foxman, Pharm. (Ret.), Senior Scientist, HPCUS. The Homeopathic Pharmacopeia Convention of the United States (HPCUS) has...
CGMPs in the HPUS — A Recap and Reminder
By Eric Foxman, Pharm. (Ret.) Current Good Manufacturing Practices (CGMPs) in 21CFR parts 210 and 211 provide a foundation for requisite quality steps during the...
Homeopathic Product Statistics in FDA’s Office of Pharmaceutical Quality Annual Report
For the sixth time, the Office of Pharmaceutical Quality (OPQ) in FDA's Center for Drug Evaluation and Research (CDER) published its "Fiscal Year 2023 Report...
Allied Organization: HOHM Research
Established in 2017 as the research arm of the HOHM Foundation, HOHM Research focuses on high-end, robust research outputs focused on the clinical work and results using...
New Peer-Reviewed Published Study on the Status of Homeopathy Taught in U.S. Pharmacy Schools
More than half (84 of 137) of U.S. schools of pharmacy that responded to a survey reported teaching homeopathy to pharmacy students. In addition, most...
AAHP Research on Safety of Homeopathy
By Mark Land, MS, RAC-US, AAHP President Each year one issue of the AAHP newsletter focuses on research. The March 2023 issue delved into basic...
